Varian receives FDA registration for Claymount Optica collimators

By News Release
0  Votes

Image Gallery

Varian Medical Systems has announced it has received U.S. Food and Drug Administration (FDA) registration for its Claymount Optica 20 and Optica 40 collimators. Claymount's Optica collimators are used to narrow the focus of X-ray beams in film-based and digital radiography systems for improving image quality and minimizing dose to patients.

The manually operated Optica 20 collimator is designed for use in human and veterinary radiography systems and can be readily installed into new or existing imaging systems. The motorized Optica 40 collimator is intended for integration into human radiography and fluoroscopy imaging systems. When integrated with the control software of the X-ray system, the Optica 40 can be used to remotely adjust the X-ray beam collimator. As described in a news release, Optica collimators feature a robust, lightweight design with a range of filtration options, including the ability to prevent patients from being exposed to useless low-energy X-ray spectrums and to meet requirements for pediatric imaging. 

"The launch of the Claymount Optica collimators is part of Varian's commitment to offer our customers one-stop shopping with a complete portfolio of X-ray components," said Carl LaCasce, vice president of sales and marketing for Varian's Imaging Components.

Back To Top

Varian receives FDA registration for Claymount Optica collimators.  Appl Rad Oncol. 

By News Release| July 19, 2016
Categories:  Technologies|Section

About the Author

News Release

News Release


Copyright © Anderson Publishing, Ltd